Open AccessFirst Clinical Cases of OXA-48-Producing Klebsiella pneumoniae in Peru
Author(s) -
Adriana Morales-Moreno,
José Carlos Ballena-López,
Roxana Sandoval-Ahumada,
Wilmer Silva-Caso,
Giancarlo Pérez-Lazo
Publication year - 2021
Publication title -
revista del cuerpo médico del hnaaa/revista del cuerpo médico hospital nacional almanzor aguinaga asenjo
Language(s) - English
Resource type - Journals
eISSN - 2227-4731
pISSN - 2225-5109
DOI - 10.35434/rcmhnaaa.2021.143.1260
Subject(s) - klebsiella pneumoniae , colistin , enterobacteriaceae , latin americans , klebsiella infections , enterobacteriaceae infections , medicine , klebsiella , public health , microbiology and biotechnology , intensive care medicine , biology , antibiotics , political science , escherichia coli , pathology , gene , biochemistry , law
Background: Carbapenemase-producing Enterobacteriaceae (CPE) represents a global public health concern and systemic infections associated with OXA-48 carbapenemase are increasingly being reported in Latin America. Here, we present the first 2 cases of systemic infections by OXA-48-Producing Klebsiella pneumoniae in Peru. A favorable clinical response was observed after targeted treatment with colistin as a backbone.